You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ipragliflozin

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Seongnam (Ipragliflozin, Sitagliptin)

Recruiting
  • Type 2 Diabetes Mellitus
  • Seongnam, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
Mar 29, 2021

Type 2 Diabetes Trial in Korea, Republic of (metformin, ipragliflozin, glimepiride)

Terminated
  • Type 2 Diabetes Mellitus
  • Busan, Korea, Republic of
  • +7 more
Apr 12, 2020

Type 2 Diabetes Trial in Japan (ipragliflozin, )

Completed
  • Type 2 Diabetes Mellitus
  • ipragliflozin
  • placebo
  • Chubu, Japan
  • +7 more
Apr 23, 2019

Type 2 Diabetes Trial in Japan (Ipragliflozin)

Completed
  • Type 2 Diabetes Mellitus
  • Ipragliflozin
  • Chubu, Japan
  • +5 more
Apr 25, 2019

Type 2 Diabetes Trial in Japan (Ipragliflozin, Insulin)

Completed
  • Type 2 Diabetes Mellitus
  • Gunma, Japan
  • +14 more
Dec 6, 2018

Diabetes Trial in Japan (ipragliflozin, Placebo)

Completed
  • Diabetes Mellitus
  • ipragliflozin
  • Placebo
  • Chubu, Japan
  • +7 more
May 20, 2019

Ipragliflozin Treatment in type2 Diabetes Patients

Completed
  • Type 2 Diabetes
  • ipragliflozin
  • Chubu, Japan
  • +7 more
Dec 3, 2018

Type 2 Diabetes Trial in Japan (ipragliflozin)

Completed
  • Type 2 Diabetes Mellitus
  • ipragliflozin
  • Chubu, Japan
  • +6 more
May 7, 2019

Type 2 Diabetes Trial in Japan (ipragliflozin, )

Completed
  • Type 2 Diabetes Mellitus
  • ipragliflozin
  • placebo
  • Hokkaido, Japan
  • +4 more
May 7, 2019

Type 2 Diabetes Trial in Japan (ipragliflozin, Placebo, metformin)

Completed
  • Type 2 Diabetes Mellitus
  • ipragliflozin
  • +2 more
  • Chubu, Japan
  • +6 more
May 7, 2019

Type 2 Diabetes Trial in Japan (ipragliflozin, Placebo, Pioglitazone)

Completed
  • Type 2 Diabetes Mellitus
  • ipragliflozin
  • +2 more
  • Chubu, Japan
  • +6 more
May 7, 2019

Type 2 Diabetes Trial in Japan (ipragliflozin, Placebo, Sulfonylurea)

Completed
  • Type 2 Diabetes Mellitus
  • ipragliflozin
  • +2 more
  • Chubu, Japan
  • +6 more
Apr 29, 2019

Type 2 Diabetes Trial in Japan (ipragliflozin, nateglinide)

Completed
  • Type 2 Diabetes Mellitus
  • Hokkaido, Japan
  • +3 more
Apr 29, 2019

Type 2 Diabetes Trial (Ipragliflozin, Sitagliptin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • (no location specified)
Aug 3, 2018

Type 2 Diabetes Trial (Ipragliflozin, Placebo, Sitagliptin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Ipragliflozin
  • +2 more
  • (no location specified)
Aug 3, 2018

Type 2 Diabetes Trial in Japan (ipragliflozin, alpha glucosidase inhibitor)

Completed
  • Type 2 Diabetes Mellitus
  • ipragliflozin
  • alpha glucosidase inhibitor
  • Chubu, Japan
  • +5 more
May 7, 2019

Type 2 Diabetes Trial (Sitagliptin, Placebo, Ipragliflozin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • (no location specified)
Aug 3, 2018

Type 2 Diabetes Trial in Japan (ipragliflozin, DPP-4 inhibitor)

Completed
  • Type 2 Diabetes Mellitus
  • ipragliflozin
  • DPP-4 inhibitor
  • Chubu, Japan
  • +5 more
Apr 29, 2019

Type 2 Diabetes Trial in Worldwide (ipragliflozin, Placebo, Metformin)

Completed
  • Type 2 Diabetes Mellitus
  • ipragliflozin
  • +2 more
  • Los Angeles, California
  • +44 more
May 20, 2019

Type 1 Diabetes Trial in Japan (ipragliflozin, Placebo, Insulin Therapy)

Completed
  • Type 1 Diabetes Mellitus
  • ipragliflozin
  • +2 more
  • Aichi, Japan
  • +35 more
Mar 5, 2019

Diabetes, Type 2 Trial in Worldwide (ipragliflozin, Metformin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • ipragliflozin
  • +2 more
  • Birmingham, Alabama
  • +58 more
May 20, 2019

Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD) Trial in Seoul (Ipragliflozin, metformin with pioglitazone)

Completed
  • Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)
  • Ipragliflozin
  • metformin with pioglitazone
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine, Department of internal Me
Jun 22, 2017

Bioavailability of Ipragliflozin, Healthy Subjects Trial in Leeds (Ipragliflozin)

Completed
  • Bioavailability of Ipragliflozin
  • Healthy Subjects
  • Ipragliflozin
  • Leeds, United Kingdom
    (unnamed)
May 31, 2012

Healthy Subjects, Pharmacokinetics of Ipragliflozin Trial in Leeds (Ipragliflozin, Furosemide)

Completed
  • Healthy Subjects
  • Pharmacokinetics of Ipragliflozin
  • Leeds, United Kingdom
    (unnamed)
May 31, 2012